TickerFacts.

Bone Biologics Corp (BBLG): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$418.6K
As of 2025-12-31
$512.0K
As of 2026-06-30
-45.2%
3-year compound annual growth
-50.2%
5-year compound annual growth
-24.8%
10-year compound annual growth
$13.69M2010-10-31: $24.0K2011-10-31: $29.0K2012-10-31: $35.1K2013-10-31: $40.2K2013-12-31: $5.70M2014-12-31: $7.52M2015-12-31: $7.23M2016-03-31: $7.55M2016-06-30: $7.71M2016-09-30: $7.73M2016-12-31: $9.06M2017-03-31: $9.54M2017-06-30: $10.54M2017-09-30: $11.85M2017-12-31: $9.19M2018-12-31: $9.64M2019-12-31: $11.90M2020-12-31: $13.69M2021-12-31: $99.9K2022-12-31: $2.55M2023-12-31: $831.4K2024-12-31: $377.7K2025-12-31: $418.6K$418.6K
2010-10-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$418.6K+10.8%2026-03-02, Balance as of period end
2024-12-31$377.7K-54.6%2026-03-02, Balance as of period end
2023-12-31$831.4K-67.4%2025-02-26, Balance as of period end
2022-12-31$2.55Mn/m2024-02-21, Balance as of period end
2021-12-31$99.9K-99.3%2023-03-30, Balance as of period end
2020-12-31$13.69M+15.1%2022-03-15, Balance as of period end
2019-12-31$11.90M+23.4%2021-04-15, Balance as of period end
2018-12-31$9.64M+4.9%2020-03-30, Balance as of period end
2017-12-31$9.19Mn/a2019-03-29, Balance as of period end
2017-09-30$11.85Mn/a2018-04-02, Balance as of period end
2017-06-30$10.54Mn/a2018-04-02, Balance as of period end
2017-03-31$9.54Mn/a2018-04-02, Balance as of period end
2016-12-31$9.06Mn/a2018-04-02, Balance as of period end
2016-09-30$7.73Mn/a2018-04-02, Balance as of period end
2016-06-30$7.71Mn/a2018-04-02, Balance as of period end
2016-03-31$7.55Mn/a2018-04-02, Balance as of period end
2015-12-31$7.23Mn/c2017-03-30, Balance as of period end
2014-12-31$7.52M+32.0%2016-03-28, Balance as of period end
2013-12-31$5.70Mn/a2015-03-31, Balance as of period end
2013-10-31$40.2K+14.5%2014-02-13, Balance as of period end
2012-10-31$35.1K+21.2%2014-02-13, Balance as of period end
2011-10-31$29.0K+20.5%2013-01-29, Balance as of period end
2010-10-31$24.0Kn/a2012-01-30, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Bone Biologics Corp (BBLG)2025-12-31$418.6K+10.8%
NutriBand Inc. (NTRB)2026-01-31$868.4K-16.6%
Regentis Biomaterials Ltd. (RGNT)2025-12-31$2.87M-55.7%
Milestone Scientific Inc. (MLSS)2025-12-31$4.99M+26.0%
Envoy Medical, Inc. (COCH)2025-12-31$20.32M-33.1%
CollPlant Biotechnologies Ltd (CLGN)2025-12-31$4.70M-10.3%
Safe Pro Group Inc. (SPAI)2025-12-31$1.40M+30.0%
Vicarious Surgical Inc. (RBOT)2025-12-31$9.74M-53.7%
LogicMark, Inc. (LGMK)2025-12-31$2.22M+9.2%

Compare BBLG, NTRB, RGNT, MLSS side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗